CNBC's Stock Pops & Drops From September 26

Loading...
Loading...
Speaking
on CNBC's Stock Pops & Drops
, Guy Adami said that it would not be wise to chase
Agios Pharmaceuticals IncAGIO
after the stock spiked 19.29 percent. The company announced new clinical data on its cancer drug. In the biotech space, Adami likes
Celgene CorporationCELG
and
Gilead Sciences, Inc.GILD
. Tim Seymour has a long position in
Altria Group IncMO
and he is keeping it after the stock jumped 1.55 percent. He also said that the company owns 20 percent in SABMiller and that investment is pumping up the value.
Altria Group Inc
got upgraded on Friday by
Bank of America Corp
Loading...
Loading...
BAC
.
Pfizer Inc.PFE
dropped 0.87 percent on the news that there will be a significant delay of the development of its sickle cell drug. Pete Najarian thinks that it was just a slight drop and he still likes the stock because it is trading at 13 forward earnings. He added that
Pfizer Inc.
was his final trade on Thursday and he likes it more after the pull back.
Micron Technology, Inc.MU
spiked 6.72 percent after the earnings and it closed the session at $33.38. Brian Kelly thinks that the stock is going to $35.
Loading...
Loading...
Posted In: CNBCMediaBrian KellyGuy AdamiPete NajarianTim Seymour
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...